drugset / Trial / NCT00743106

The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery

NCT00743106

Terminated 90 enrolled The Cleveland Clinic
RandomizedParallel-groupDouble-blindPrevention

Summary

This trial will study the effects of fenoldopam on renal function in patients who have a single kidney undergoing surgery to remove part of that kidney secondary to renal cell carcinoma. The investigators will monitor and evaluate throughout the perioperative course the kidney function. Normally kidney function is predicted to show a worsening followed by an improvement after surgery. The investigators want to specifically identify if the use of fenoldopam lessens the injury to the kidney with this surgery.

Timeline

Start
2002-09
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenoldopam Small molecule 0.1 ug/kg

Indications

No indication recorded.